These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Dose-dependent effects of in vivo antithymocyte globulin during conditioning for allogeneic bone marrow transplantation from unrelated donors in patients with chronic phase CML. Schleuning M, Günther W, Tischer J, Ledderose G, Kolb HJ. Bone Marrow Transplant; 2003 Aug; 32(3):243-50. PubMed ID: 12858194 [Abstract] [Full Text] [Related]
4. Comparison of two doses of antithymocyte globulin in patients undergoing matched unrelated donor allogeneic stem cell transplantation. Ayuk F, Diyachenko G, Zabelina T, Wolschke C, Fehse B, Bacher U, Erttmann R, Kröger N, Zander AR. Biol Blood Marrow Transplant; 2008 Aug; 14(8):913-9. PubMed ID: 18640575 [Abstract] [Full Text] [Related]
6. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden. Warlick ED, Cioc A, Defor T, Dolan M, Weisdorf D. Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940 [Abstract] [Full Text] [Related]
7. In vitro and in vivo T-cell depletion with myeloablative or reduced-intensity conditioning in pediatric hematopoietic stem cell transplantation. Seidel MG, Fritsch G, Matthes-Martin S, Lawitschka A, Lion T, Pötschger U, Rosenmayr A, Fischer G, Gadner H, Peters C. Haematologica; 2005 Oct; 90(10):1405-14. PubMed ID: 16219578 [Abstract] [Full Text] [Related]
9. Bone marrow transplantation from partially HLA-mismatched family donors for acute leukemia: single-center experience of 201 patients. Mehta J, Singhal S, Gee AP, Chiang KY, Godder K, Rhee Fv Fv, DeRienzo S, O'Neal W, Lamb L, Henslee-Downey PJ. Bone Marrow Transplant; 2004 Feb; 33(4):389-96. PubMed ID: 14716338 [Abstract] [Full Text] [Related]
10. Adult recipients of matched related donor blood cell transplants given myeloablative regimens including pretransplant antithymocyte globulin have lower mortality related to graft-versus-host disease: a matched pair analysis. Russell JA, Turner AR, Larratt L, Chaudhry A, Morris D, Brown C, Quinlan D, Stewart D. Biol Blood Marrow Transplant; 2007 Mar; 13(3):299-306. PubMed ID: 17317583 [Abstract] [Full Text] [Related]
11. Outcome of T cell-depleted transplantation after conditioning with an intensified regimen in patients aged 50 years or more is comparable with that in younger patients. Schattenberg A, Schaap N, Preijers F, van der Maazen R, de Witte T. Bone Marrow Transplant; 2000 Jul; 26(1):17-22. PubMed ID: 10918401 [Abstract] [Full Text] [Related]
12. Successful prevention of acute graft-versus-host disease using low-dose antithymocyte globulin after mismatched, unrelated, hematopoietic stem cell transplantation for acute myelogenous leukemia. Kim HJ, Min WS, Cho BS, Eom KS, Kim YJ, Min CK, Lee S, Cho SG, Jin JY, Lee JW, Kim CC. Biol Blood Marrow Transplant; 2009 Jun; 15(6):704-17. PubMed ID: 19450755 [Abstract] [Full Text] [Related]
16. Outcome of allogeneic bone marrow transplantation with lymphocyte-depleted marrow grafts in adult patients with myelodysplastic syndromes. Mattijssen V, Schattenberg A, Schaap N, Preijers F, De Witte T. Bone Marrow Transplant; 1997 Apr; 19(8):791-4. PubMed ID: 9134170 [Abstract] [Full Text] [Related]